Forward Pharma A/S P/E Ratio

Forward Pharma A/S's p/e ratio stands at 2166.67. That is above the Healthcare sector average of 19.01. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Forward Pharma A/S sits higher the Healthcare benchmark (19.01) with a P/E ratio of 2166.67. That is roughly 11297.5% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Whether 2166.67 is attractive depends on Forward Pharma A/S's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.

The history chart shows how Forward Pharma A/S's P/E ratio evolved across reporting periods, while the comparison chart places FWP next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, P/E ratio is commonly used to spot outliers. Forward Pharma A/S's reading of 2166.67 (sector avg 19.01) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.